Developmental Funds have been essential for catalyzing growth and developing scientific depth for the Simmons Cancer Center's scientific programs. A planning and evaluation process sets strategic and programmatic priorities with input from program leaders and oversight by senior leadership and external advisors. The Simmons Cancer Center has grown rapidly over the past 4 years with strong philanthropic and institutional support for recruitment of new scientists and clinical investigators from outside the institution. Institutional resources have been committed for the continued expansion of the Cancer Center with plans for recruitment of 15 new faculty to address areas of strategic need within the Center. Particular emphasis will be on the development of a program of excellence in breast cancer, an early phase clinical trials initiative with particular focus in phase I trials, and a cancer control and population science program that focuses on behavioral and health communication research. Developmental Funds from the Cancer Center Support Grant will be used to support (1) new investigator projects;and (2) pilot projects that will encourage new areas of cancer research. The CCSG funds will be supplemented with institutional resources to provide funding for 8 new investigator awards at $40,000 each and to provide $200,000 for pilot projects. A new investigator project oversight committee will evaluate and rank pilot projects for funding. Advocacy for novel innovative and high risk pilot projects will come from program leadership and be evaluated for support by the Senior Leadership Council.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-04
Application #
8519954
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$113,630
Indirect Cost
$27,467
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
LaRanger, Ryan; Peters-Hall, Jennifer R; Coquelin, Melissa et al. (2018) Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells. Tissue Eng Part A 24:559-568
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Kim, Wanil; Shay, Jerry W (2018) Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD). Differentiation 99:1-9
Li, Shulong; Yang, Ning; Li, Bin et al. (2018) A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT. Med Image Anal 50:106-116
Wang, Shidan; Chen, Alyssa; Yang, Lin et al. (2018) Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome. Sci Rep 8:10393
An, Weiwei; Mason, Ralph P; Lippert, Alexander R (2018) Energy transfer chemiluminescence for ratiometric pH imaging. Org Biomol Chem 16:4176-4182
O'Kelly, Devin; Zhou, Heling; Mason, Ralph P (2018) Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics. J Biomed Opt 23:1-6
Chen, Yan; Zhang, Bo; Bao, Lei et al. (2018) ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest 128:1937-1955
Stallings, Nancy R; O'Neal, Melissa A; Hu, Jie et al. (2018) Pin1 mediates A?42-induced dendritic spine loss. Sci Signal 11:
Sudhan, Dhivya R; Schwarz, Luis J; Guerrero-Zotano, Angel et al. (2018) Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial. Clin Cancer Res :

Showing the most recent 10 out of 501 publications